Compresion Therapy50506NCT03192982
Post-operative Complication, Impulsive Compression, in Situ Bypass
A study testing A-V impulse 6000 Series and Standard treatment (compression) in people with Compresion Therapy and Post-operative Edema, run by Kolding Sygehus at 1 site in Denmark.
Trial summary
To investigate whether compression therapy with foot pump reduce post-operative edema, facilitate wound healing of operation wounds, promote healing of ischemic ulcers and shorten hospitalization, increase and improve the patient's subjective quality of life faster Read more about this study
- Who is it for?
- Ages 18 to 99 years
- Conditions the study is for
- Compresion Therapy, Post-operative Edema, Wound Complication
- What is being tested?
- A-V impulse 6000 Series and Standard treatment (compression)
- Type of treatment
- Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 100 participants
- Where
- 1 siteDenmark
- Study dates
- 8 Feb 2018to 30 Nov 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 99 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients who need an insitu bypass from Common Femoral Artery to Popliteal AK/BK or crural Artery
Who cannot join
- Ischemic wound that are located in such manner that compression of the foot is not possible. Former deep vein trombosis (DVT) or symptomatic post thrombotic syndrome (PTS) We only include patients without any connections to other studies-
Trial locations and contacts
1 site in 1 country.
Denmark1 site, 1 recruiting
- Recruiting
Hans Ravn
Kolding, 6000
Hans Ravn, MD. Ph.D, 004528718505, hans.ravn@rsyd.dk
Tenna Klit, MD, tenna.klit@rsyd.dk
About this study
Official title: Impact on Expected Post-operative Complications With Impulsive Compression of Vein Complexes in Foot of Patients Operated on With In-situ Bypass for Acute/Chronic Leg Ischemia
To investigate whether compression therapy with foot pump reduce post-operative edema, facilitate wound healing of operation wounds, promote healing of ischemic ulcers and shorten hospitalization, increase and improve the patient's subjective quality of life faster
Read the detailed description
Impact on expected post-operative complications with impulsive compression of vein complexes in foot of patient operated on with insitu bypass for acute/chronic leg ischemia.
Purpose/aim:
To investigate whether compression therapy with foot pump reduce post-operative edema, facilitate wound healing of the operation wounds, promote healing of ischemic ulcers and shorten hospitalization, increase and improve the patient's subjective quality of life faster.
Background:
Insitu bypass to the lower extremity are the standard operation choice on patients with critical leg ischemia. Approximately 18% of patients wound problems, which prolong their hospitalization time and convalescence. One of the reasons for wound problems is swelling, which occurs in connection with the legs process of revascularization (angiogenesis). One can expect that the leg, 10 cm below the patella will undergo swelling with approximately 6-8% during the first day, and up to 8-10% after four days in connection with the inset bypass surgery. Early mobilization can prevent the swelling to become too pronounced. By mobilizing you stimulate the natural venous pump in the leg. Patients are often hard to mobilize in an early stage due to the wound and age. Stimulation of the venous plexus in the arch of the foot has in other categories of patients shown to reduce swellings of leg and thrombosis risk in patients undergoing orthopedic surgery on the lower extremities .
There is no description of treatment of Vascular surgical patients with foot pump to be found in literature.
The patient's subjective quality of life is often impaired in relation to the above mentioned surgical treatment. A quicker recovery can be compatible with rapidly regained quality of life.
There is no analysis or meta Cochrane reviews in this field.
Plan and material:
- Procedure: Patients follow the normal procedure in the department in terms of insitu bypass.
Asked in the outpatient's clinic at visit for preparation for the operation.
- Method:
Time schedule for measuring assessing symptoms as pain, edema and swelling:
Measuring the leg swelling
- The night before the operation.
- The day after the operation.
- Day 4 and the day of patient discharge.
- Day 30 (control in our open clinic for control of the operation results). The measure procedure will be as follows: The circumference of the leg will be measured at 10 cm below the distal part of the patellae. In the same procedure pain by the Visual analogue scale (VAS) will evaluated and edema at the ankle in the same leg by digital pulpal pressure on the skin. The r reaction will be noted (fast recovery or slow) the depth of the dimple will be noted. Operation is planned. Post operation, foot pump is placed on foot, according to randomization. Pump must be placed on foot immediately after arrival to ICU. Foot pump will be left on foot until full mobilization is reached. The control group follows the department's ordinary post-operative routines for inset bypass, i.e. compression stockings or short-stretch bandage. The compression stocking is a TED stocking with 18 mmHg pressure at the ankle and short-stretch bandage is a padded bandage that stretch from the toes and up to the upper thigh with a 40 mmHg pressure. Time for full mobilization is recorded in all patients. Reoperations is noted. Toe pressure is measured at inclusion, immediately post-op and at discharge. Time for discharge is noted. Para clinical factors to be examined. Duplex study of reverse flow in the deep veins associated with standard duplex study of AV fistulas post-operatively. Quality of life questionnaire (vascu Qol) EQ-5D baseline + 6-month
- Risks, side effects and disadvantages: The foot pump treatment is non-invasive. Patients bear no ache nor pain in connection with the treatment method. The pump is used in other European countries on an empirical basis and CE mark. Duplex study is done as routine examinations in the department and is non-invasive. The side effects and risks of pump therapy can be considered as insignificant.
- Patient integrity: The project reported to the data monitoring via the regions" paraplyanmelselse" to the data inspectorate. The law on treatment of personal data will be respected.
- Data application sheet: A data application sheet will be created for all the included patients. The information will be fed into the database for analysis. Usernames and passwords will be created for login for all trial related personnel.
- Publication: The results of the study will be presented at national and international meetings and conventions. The end result will be published in an international magazine.
- Ethical considerations: Wound complications associated with vascular surgery is a major problem for both patients and vascular surgeons. All that is possible to bring the infection rate down is good for patients and hospital systems. If we simultaneously can shorten the hospitalization time and improve the quality of life for patients, it will mean that we have accomplishment. This study is a win-win project without inflicting the trial subjects no significant risks or side effects. For research and surgical discipline, it can be of great importance to show the advantage with the foot pump treatment in a study. And thereby awaken the interest in foot pumps among other medical specialities.
- Informed consent: Patients with critical leg ischemia, where there are taken a decision on inset bypass, is offered to participate in the trial by ambulatory visit. There will be a sheet with written information handed out and the patients will also receive information orally about the trial. The patient now has the option for consideration until the randomization will happen at admission to operation. The oral information will be given by the research nurse and study physician. The patient and Doctor/nurse call on a study room in the outpatient clinic at Department of Vascular surgery, Hospital Lillebaelt, Denmark.. The patient is given the written information to take home for reading and have the opportunity to have an observer present at the hospital where the patient must submit a statement of participation in the study. The tome between ambulatory visit and hospitalization in usually seven to 14 days depending on the severity of the patient's ischemia.
- Patient Insurance: The subject is covered by the patient compensation scheme in the region of southern Denmark.
- Conditions
- Compresion Therapy, Post-operative Edema, Wound Complication, Ischemia Limb, Quality of Life
- Being tested
- A-V impulse 6000 Series, Standard treatment (compression)
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
A-V impulse 6000 SeriesDevice
foot pad and pump
Standard treatment (compression)Device
Short-stretch bandage from toes and up yo the upper thigh 40 mm Hg
| Study group | Role | What they receive |
|---|---|---|
| Foot pump (A-V Impulse, 6000 Series) | Experimental | In OR before operation starts randomized to foot pump treatment post operative. Pump placed on foot immediately after operation is finished. Foot pump will be left on foot until full mobilization is reached Receives: Device: A-V impulse 6000 Series |
| Standard treatment (compression) | Active comparator | In OR before operation starts randomized to standart treatment for edema after in situ bypass.
Short-stretch bandage from toes and up yo the upper thigh 40 mm Hg Receives: Device: Standard treatment (compression) |
What is being measured
The primary outcome is the main question the study is designed to answer.
Reduction of wound complications in the foot pump group
reduction from 18% to 14 %.Inspection of the operated leg at day 2 and 4 and at discharging. After discharging at 30 days, 6 month and one year.More frequent inspections can be necessary depending on the situation and the condition of the patient.
Inspection of secretion from the operations cicatrices, necrosis and diastasis of the wounds, signs of infections, hematoma subcutaneously in the operation area, edema, temperature and color of the skin
Measured: From randomization until 12 month examination (individual finish examination)
Secondary outcomes (3)
Reduction of leg edema 50%,
10 cm below the patella on the operated leg three days post-operation in patients treated with impulsive compression in comparison to non-treated.
Measured: 5 to 30 days
Time to mobilization in pump treated patients
Patient can get out of bed and go to the toilet.
Measured: 1 to 7 days
Length of stay in hospital
Measured: 10 to 14 Days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Jun 2017
- Study start8 Feb 2018
- Primary completion28 Nov 2022 (estimated)
- Study completion30 Nov 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Compresion TherapyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Model description
- Randomized prospective study
- Masking
- None (open label)
- Enrolment
- 100 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Kolding Sygehus
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hans Ravn, Vejle Hospital
- Investigators
- Hans Ravn, MD PhD, Study chair, Vejle Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03192982
- Sponsor's protocol ID
- Impulsive compression i insitu
- Acronym
- 50506
- Status last verified
- Sep 2020
- First submitted
- 29 May 2017
- Last updated
- 16 Sep 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes
Publications
Klit T, Dahl M, Houlind KC, Ravn H. Effect of Impulsive Compression Treatment on Postoperative Complications After Open Peripheral Vascular Revascularization (In Situ): Protocol for a Randomized Control Trial. JMIR Res Protoc. 2018 Feb 20;7(2):e58. doi: 10.2196/resprot.8799.
PubMed 29463493
Study at a glance
From the registry record, last updated by the sponsor on 16 Sep 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Impact on Expected Post-operative Complications With Impulsive Compression of Vein Complexes in Foot of Patients Operated on With In-situ Bypass for Acute/Chronic Leg Ischemia
- ClinicalTrials.gov ID
- NCT03192982
- Acronym / sponsor ID
- 50506 / Impulsive compression i insitu
- Conditions
- Compresion Therapy, Post-operative Edema, Wound Complication, Ischemia Limb, Quality of Life
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 100 participants (estimated)
- Lead sponsor
- Kolding SygehusUniversity, hospital or other
- Study start
- 8 Feb 2018 (actual)
- Primary completion
- 28 Nov 2022 (estimated)
- Study completion
- 30 Nov 2022 (estimated)
- First posted
- 20 Jun 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To investigate whether compression therapy with foot pump reduce post-operative edema, facilitate wound healing of operation wounds, promote healing of ischemic ulcers and shorten hospitalization, increase and improve the patient's subjective quality of life faster
Detailed description
Impact on expected post-operative complications with impulsive compression of vein complexes in foot of patient operated on with insitu bypass for acute/chronic leg ischemia.
Purpose/aim:
To investigate whether compression therapy with foot pump reduce post-operative edema, facilitate wound healing of the operation wounds, promote healing of ischemic ulcers and shorten hospitalization, increase and improve the patient's subjective quality of life faster.
Background:
Insitu bypass to the lower extremity are the standard operation choice on patients with critical leg ischemia. Approximately 18% of patients wound problems, which prolong their hospitalization time and convalescence. One of the reasons for wound problems is swelling, which occurs in connection with the legs process of revascularization (angiogenesis). One can expect that the leg, 10 cm below the patella will undergo swelling with approximately 6-8% during the first day, and up to 8-10% after four days in connection with the inset bypass surgery. Early mobilization can prevent the swelling to become too pronounced. By mobilizing you stimulate the natural venous pump in the leg. Patients are often hard to mobilize in an early stage due to the wound and age. Stimulation of the venous plexus in the arch of the foot has in other categories of patients shown to reduce swellings of leg and thrombosis risk in patients undergoing orthopedic surgery on the lower extremities .
There is no description of treatment of Vascular surgical patients with foot pump to be found in literature.
The patient's subjective quality of life is often impaired in relation to the above mentioned surgical treatment. A quicker recovery can be compatible with rapidly regained quality of life.
There is no analysis or meta Cochrane reviews in this field.
Plan and material:
- Procedure: Patients follow the normal procedure in the department in terms of insitu bypass.
Asked in the outpatient's clinic at visit for preparation for the operation.
- Method:
Time schedule for measuring assessing symptoms as pain, edema and swelling:
Measuring the leg swelling
- The night before the operation.
- The day after the operation.
- Day 4 and the day of patient discharge.
- Day 30 (control in our open clinic for control of the operation results). The measure procedure will be as follows: The circumference of the leg will be measured at 10 cm below the distal part of the patellae. In the same procedure pain by the Visual analogue scale (VAS) will evaluated and edema at the ankle in the same leg by digital pulpal pressure on the skin. The r reaction will be noted (fast recovery or slow) the depth of the dimple will be noted. Operation is planned. Post operation, foot pump is placed on foot, according to randomization. Pump must be placed on foot immediately after arrival to ICU. Foot pump will be left on foot until full mobilization is reached. The control group follows the department's ordinary post-operative routines for inset bypass, i.e. compression stockings or short-stretch bandage. The compression stocking is a TED stocking with 18 mmHg pressure at the ankle and short-stretch bandage is a padded bandage that stretch from the toes and up to the upper thigh with a 40 mmHg pressure. Time for full mobilization is recorded in all patients. Reoperations is noted. Toe pressure is measured at inclusion, immediately post-op and at discharge. Time for discharge is noted. Para clinical factors to be examined. Duplex study of reverse flow in the deep veins associated with standard duplex study of AV fistulas post-operatively. Quality of life questionnaire (vascu Qol) EQ-5D baseline + 6-month
- Risks, side effects and disadvantages: The foot pump treatment is non-invasive. Patients bear no ache nor pain in connection with the treatment method. The pump is used in other European countries on an empirical basis and CE mark. Duplex study is done as routine examinations in the department and is non-invasive. The side effects and risks of pump therapy can be considered as insignificant.
- Patient integrity: The project reported to the data monitoring via the regions" paraplyanmelselse" to the data inspectorate. The law on treatment of personal data will be respected.
- Data application sheet: A data application sheet will be created for all the included patients. The information will be fed into the database for analysis. Usernames and passwords will be created for login for all trial related personnel.
- Publication: The results of the study will be presented at national and international meetings and conventions. The end result will be published in an international magazine.
- Ethical considerations: Wound complications associated with vascular surgery is a major problem for both patients and vascular surgeons. All that is possible to bring the infection rate down is good for patients and hospital systems. If we simultaneously can shorten the hospitalization time and improve the quality of life for patients, it will mean that we have accomplishment. This study is a win-win project without inflicting the trial subjects no significant risks or side effects. For research and surgical discipline, it can be of great importance to show the advantage with the foot pump treatment in a study. And thereby awaken the interest in foot pumps among other medical specialities.
- Informed consent: Patients with critical leg ischemia, where there are taken a decision on inset bypass, is offered to participate in the trial by ambulatory visit. There will be a sheet with written information handed out and the patients will also receive information orally about the trial. The patient now has the option for consideration until the randomization will happen at admission to operation. The oral information will be given by the research nurse and study physician. The patient and Doctor/nurse call on a study room in the outpatient clinic at Department of Vascular surgery, Hospital Lillebaelt, Denmark.. The patient is given the written information to take home for reading and have the opportunity to have an observer present at the hospital where the patient must submit a statement of participation in the study. The tome between ambulatory visit and hospitalization in usually seven to 14 days depending on the severity of the patient's ischemia.
- Patient Insurance: The subject is covered by the patient compensation scheme in the region of southern Denmark.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
- Model description
- Randomized prospective study
| Arm | Type | Receives |
|---|---|---|
| Foot pump (A-V Impulse, 6000 Series) | Experimental | Device: A-V impulse 6000 SeriesIn OR before operation starts randomized to foot pump treatment post operative. Pump placed on foot immediately after operation is finished. Foot pump will be left on foot until full mobilization is reached |
| Standard treatment (compression) | Active comparator | Device: Standard treatment (compression)In OR before operation starts randomized to standart treatment for edema after in situ bypass. Short-stretch bandage from toes and up yo the upper thigh 40 mm Hg |
Who may qualify
- Ages
- 18 to 99 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- Patients who need an insitu bypass from Common Femoral Artery to Popliteal AK/BK or crural Artery
Key exclusion criteria (1 listed)
- Ischemic wound that are located in such manner that compression of the foot is not possible. Former deep vein trombosis (DVT) or symptomatic post thrombotic syndrome (PTS) We only include patients without any connections to other studies-
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| A-V impulse 6000 Seriesfoot pad and pump | Device | Foot pump (A-V Impulse, 6000 Series) |
| Standard treatment (compression)Short-stretch bandage from toes and up yo the upper thigh 40 mm Hg | Device | Standard treatment (compression) |
Primary outcome
Reduction of wound complications in the foot pump group
Time frame: From randomization until 12 month examination (individual finish examination)
reduction from 18% to 14 %.Inspection of the operated leg at day 2 and 4 and at discharging. After discharging at 30 days, 6 month and one year.More frequent inspections can be necessary depending on the situation and the condition of the patient. Inspection of secretion from the operations cicatrices, necrosis and diastasis of the wounds, signs of infections, hematoma subcutaneously in the operation area, edema, temperature and color of the skin
3 secondary outcomes
Reduction of leg edema 50%,
Time frame: 5 to 30 days
Time to mobilization in pump treated patients
Time frame: 1 to 7 days
Length of stay in hospital
Time frame: 10 to 14 Days
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Sep 2020.
- Derived from this study: PubMed 29463493Klit T, Dahl M, Houlind KC, Ravn H. Effect of Impulsive Compression Treatment on Postoperative Complications After Open Peripheral Vascular Revascularization (In Situ): Protocol for a Randomized Control Trial. JMIR Res Protoc. 2018 Feb 20;7(2):e58. doi: 10.2196/resprot.8799.
- Individual participant dataSharing planned: Yes
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Hans Ravn, MD PhD study chair
Vejle Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing A-V impulse 6000 Series and Standard treatment (compression) in people with Compresion Therapy and Post-operative Edema, run by Kolding Sygehus at 1 site in Denmark.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Sep 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Denmark. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Hans Ravn, MD PhD (004528718505, hans.ravn@rsyd.dk), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Reduction of wound complications in the foot pump group (time frame: From randomization until 12 month examination (individual finish examination)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03192982, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Sep 2020.